Previous 10 | Next 10 |
Avidity Biosciences Announces 2024 Corporate Priorities and Catalysts for Next Stage of Growth PR Newswire Avidity plans to initiate global Phase 3 HARBOR ™ trial of AOC 1001 for DM1 mid-2024 Company to report data from all three ongoing clinical program...
2023-12-24 16:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-19 13:52:09 ET Summary Today, we take our first look at Avidity Biosciences, Inc., a clinical-stage biotech company. The company is focused on developing antibody oligonucleotide conjugates to treat serious diseases and recently expanded a partnership with Bristol-Myers Sq...
Avidity Biosciences Reports Positive Data Demonstrating AOC 1044 Delivers Unprecedented Concentrations of PMO in Muscle Following a Single Dose in Healthy Volunteers from Phase 1/2 EXPLORE44™ Trial for Duchenne Muscular Dystrophy PR Newswire AOC 1044 delivered up to 50-...
2023-11-29 12:24:37 ET DENVER, Colo., Nov. 29, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Vivos Therapeutics Inc (NASDAQ: VVOS), Redhill Biopharma Ltd (NASDAQ: RDHL), GameStop Corp (NYSE: GME)...
2023-11-28 20:24:39 ET DENVER, Colo., Nov. 28, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Avidity Biosciences Inc (NASDAQ: RNA), Bristol-Myers Squibb Co (NYSE: BMY), ESGL Holdings Ltd (NASDAQ:...
2023-11-28 12:33:30 ET DENVER, Colo., Nov. 28, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Icecure Medical Ltd (NASDAQ: ICCM), Avidity Biosciences Inc (NASDAQ: RNA), ESGL Holdings Ltd (NASDAQ: ...
2023-11-28 09:56:54 ET DENVER, Colo., Nov. 28, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Avidity Biosciences Inc (NASDAQ: RNA), Bristol-Myers Squibb Co (NYSE: BMY), ESGL Holdings Ltd (NASDAQ: ESGL),...
2023-11-28 07:35:29 ET DENVER, Colo., Nov 28, 2023 ( www.247marketnews.com )- Avidity Biosciences, Inc. (NASDAQ: RNA) reported, this morning, that it expanded its global licensing and research collaboration with Bristol Myers Squibb (NYSE: BMY) fixated on discovery, development and comm...
2023-11-28 07:14:20 ET More on Bristol-Myers, Avidity, etc. Bristol-Myers Squibb Is A Great Buy, But These 5+% Yielding Bargains Are Better Bristol-Myers Squibb: The Patent Expiry Challenge Bristol Myers Squibb: A Bitter Pill But Still A Buy J&J, Merck, B...
News, Short Squeeze, Breakout and More Instantly...
Avidity Biosciences Inc. Company Name:
RNA Stock Symbol:
NASDAQ Market:
Avidity Biosciences, Inc. (NASDAQ: RNA) is the focus of IBN's latest stock spotlight. The company's shares have moved 1.12% on the day to $29.83. Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonuc...
Avidity Biosciences Announces Appointment of Simona Skerjanec to Board of Directors PR Newswire SAN DIEGO , May 15, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics c...
Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights PR Newswire Initiation of global Phase 3 HARBOR ™ trial for d el-desiran (AOC 1001) in DM1 on track for this quarter Avidity to report FSHD data from FORTI...